Aurobindo repurchases $10 million in 0% convertibles due 2011

By Devika Patel

Knoxville, Tenn., March 4 - Aurobindo Pharma Ltd. informed the Singapore Stock Exchange that it bought back and cancelled $10 million of it $200 million in zero-coupon convertible bonds due 2011.

The company bought back $5 million each of the tranche A and tranche B bonds.

Aurobindo is a pharmaceutical company located in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.